CDKN2B and neoplasm: Additionally, CDKN2B‐AS1 SNPs were correlated with larger tumour sizes (rs11333048) in thyroid [23] and oral cancers [24], as well as with higher TNM (tumour, node, metastasis) stages and increased metastasis risk (rs3217992) in bone cancer [25].